Statins may cut death risk in breast cancer patients

04/24/2013 | Family Practice News

An analysis of data from more than 30,000 breast cancer patients in Finland showed that statin use before and after diagnosis was linked to reduced mortality risk of up to 66%. "The association held for both localized and metastatic tumors. There really appears to be something going on here, and it's certainly a reason for further study," a researcher said. The findings were presented at the annual meeting of the American Association for Cancer Research.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD